Tricida Top Management
TCDADelisted Stock | USD 0.01 0.0001 0.71% |
Tricida employs about 57 people. The company is managed by 19 executives with a total tenure of roughly 124 years, averaging almost 6.0 years of service per executive, having 3.0 employees per reported executive. Analysis of Tricida's management performance can provide insight into the company performance.
Gerrit Klaerner CEO President CEO, Member of the Board of Directors |
David Bonita Chairman Chairman of the Board |
Tricida |
Tricida Management Team Effectiveness
The company has return on total asset (ROA) of (0.6011) % which means that it has lost $0.6011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2371) %, meaning that it created substantial loss on money invested by shareholders. Tricida's management efficiency ratios could be used to measure how well Tricida manages its routine affairs as well as how well it operates its assets and liabilities.Tricida Workforce Comparison
Tricida is rated below average in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 80,114. Tricida adds roughly 57.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Tricida Notable Stakeholders
A Tricida stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tricida often face trade-offs trying to please all of them. Tricida's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tricida's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gerrit Klaerner | President CEO, Member of the Board of Directors | Profile | |
David Bonita | Chairman of the Board | Profile | |
Klaus Veitinger | Independent Chairman of the Board | Profile | |
Jerry Buysse | Senior Vice President Chief Scientific Officer | Profile | |
Wilhelm Stahl | Senior Vice President CTO | Profile | |
Edward Hejlek | Senior Vice President General Counsel | Profile | |
Geoffrey Parker | CFO, Senior Vice President | Profile | |
Claire Lockey | Senior Vice President and Chief Development Officer | Profile | |
Jeroen Beek | Chief Commercial Officer and Senior Vice President | Profile | |
Dawn Parsell | Senior Vice President - Clinical Development | Profile | |
Susannah Cantrell | Senior Vice President Chief Commercial Officer | Profile | |
Robert Alpern | Independent Director | Profile | |
David Hirsch | Independent Director | Profile | |
Sandra Coufal | Independent Director | Profile | |
Kathryn Falberg | Independent Director | Profile | |
JD Esq | Ex Property | Profile | |
Annie Yoshiyama | VP Officer | Profile | |
Robert JD | Company VP | Profile | |
Jackie Cossmon | VP Communications | Profile |
About Tricida Management Performance
The success or failure of an entity such as Tricida often depends on how effective the management is. Tricida management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tricida management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tricida management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It focuses on the development and commercialization of veverimer , a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Tricida operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.
The data published in Tricida's official financial statements usually reflect Tricida's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Tricida. For example, before you start analyzing numbers published by Tricida accountants, it's critical to develop an understanding of what Tricida's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Tricida's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tricida's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Tricida's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tricida. Please utilize our Beneish M Score to check the likelihood of Tricida's management manipulating its earnings.
Tricida Workforce Analysis
Traditionally, organizations such as Tricida use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tricida within its industry.Tricida Manpower Efficiency
Return on Tricida Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 3.1M | |
Net Loss Per Executive | 9.3M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Tricida information on this page should be used as a complementary analysis to other Tricida's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Tricida Stock
If you are still planning to invest in Tricida check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tricida's history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |